# Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)

> **NCT00603798** · PHASE3 · COMPLETED · sponsor: **Graceway Pharmaceuticals, LLC** · enrollment: 490 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Imiquimod cream
- **DRUG:** Placebo cream
- **DRUG:** Imiquimod cream

## Key facts

- **NCT ID:** NCT00603798
- **Lead sponsor:** Graceway Pharmaceuticals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2010-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603798, "Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00603798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*